Abivax (ABVX) Long-Term Debt Issuances (2024 - 2026)
Abivax's (ABVX) quarterly Long-Term Debt Issuances came in at $1.3 million in Q1 2026, down 14.95% quarter-over-quarter from $1.5 million in Q4 2025.
Abivax (ABVX) Long-Term Debt Issuances (2024 - 2026) Analysis & Trends
Abivax's Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 95.86% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, changed N/A from the prior year.
- Long-Term Debt Issuances fell to $1.3 million in Q1 2026 per ABVX's latest filing, from $1.5 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $26.8 million in Q1 2024 and bottomed at -$658931.7 in Q3 2024.
- The 3-year median for Long-Term Debt Issuances is $1.5 million (2025), against an average of $10.9 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2024 | -658,931.70 |
| Sep 30, 2024 | -658,931.70 |
| Jun 30, 2024 | 25.76 Mn |
| Jun 30, 2024 | 25.76 Mn |
| Mar 31, 2024 | 26.75 Mn |
| Mar 31, 2024 | 26.75 Mn |